Bevacizumab

Common brands: Avastin, Carboplatin, Kyxata, Oxaliplatin, Efudex

Top reporter: Genentech, Inc.

Vascular Endothelial Growth Factor Inhibitor [EPC]Platinum-based Drug [EPC]Nucleoside Metabolic Inhibitor [EPC]Microtubule Inhibitor [EPC]Programmed Death Receptor-1 Blocking Antibody [EPC]
120,853
Total Reports
52,978
Serious Reports
27,863
Death Reports
30
Reported Reactions
Death Report Ratio: High (23.06%)

Patient Demographics

Male
45,298
Female
53,638

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Bevacizumab.

# Reaction Reports % of Total
1 OFF LABEL USE 13,964
10.9%
2 DEATH 13,108
10.3%
3 DISEASE PROGRESSION 7,277
5.7%
4 DIARRHOEA 7,246
5.7%
5 NAUSEA 6,413
5.0%
6 FATIGUE 6,296
4.9%
7 HYPERTENSION 5,780
4.5%
8 VOMITING 4,891
3.8%
9 ANAEMIA 4,368
3.4%
10 PYREXIA 3,995
3.1%
11 NEUTROPENIA 3,937
3.1%
12 ASTHENIA 3,494
2.7%
13 DECREASED APPETITE 3,400
2.7%
14 DYSPNOEA 3,367
2.6%
15 THROMBOCYTOPENIA 3,295
2.6%
16 DRUG INEFFECTIVE 3,202
2.5%
17 PROTEINURIA 3,012
2.4%
18 NEUROPATHY PERIPHERAL 2,868
2.2%
19 ABDOMINAL PAIN 2,826
2.2%
20 MALIGNANT NEOPLASM PROGRESSION 2,658
2.1%
21 HEADACHE 2,342
1.8%
22 RASH 2,324
1.8%
23 CONSTIPATION 2,280
1.8%
24 NO ADVERSE EVENT 2,248
1.8%
25 INTENTIONAL PRODUCT USE ISSUE 2,247
1.8%
26 PAIN 2,247
1.8%
27 PLATELET COUNT DECREASED 2,221
1.7%
28 FEBRILE NEUTROPENIA 2,137
1.7%
29 EPISTAXIS 2,124
1.7%
30 MYELOSUPPRESSION 2,063
1.6%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.